Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | 36499658 | PubTator, text mining | PubMed |
| IL-1RAP, a Key Therapeutic Target in Cancer. | Int J Mol Sci | 2022 | 36499246 | PubTator, text mining | PubMed |
| IL-33 and the Cytokine Storm in COVID-19: From a Potential Immunological Relationship towards Precision Medicine. | Int J Mol Sci | 2022 | 36498859 | PubTator, text mining | PubMed |
| Stem-Cell-Derived β-Like Cells with a Functional PTPN2 Knockout Display Increased Immunogenicity. | Cells | 2022 | 36497105 | PubTator, text mining | PubMed |
| Progress in Research on TLR4-Mediated Inflammatory Response Mechanisms in Brain Injury after Subarachnoid Hemorrhage. | Cells | 2022 | 36497041 | PubTator, text mining | PubMed |
| Machine Learning Modeling of Protein-intrinsic Features Predicts Tractability of Targeted Protein Degradation. | Genomics Proteomics Bioinformatics | 2022 | 36494034 | PubTator, text mining | PubMed |
| Targeting inflammation in lower-risk MDS. | Hematology Am Soc Hematol Educ Program | 2022 | 36485128 | PubTator, text mining | PubMed |
| Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives. | Biomark Res | 2022 | 36476317 | PubTator, text mining | PubMed |
| Targeted Protein Degradation: Design Considerations for PROTAC Development. | Curr Protoc | 2022 | 36469581 | PubTator, text mining | PubMed |
| Exploration of the shared gene signatures and molecular mechanisms between atherosclerosis and rheumatoid arthritis via multi-microarray data analyses. | Ann Transl Med | 2022 | 36467363 | PubTator, text mining | PubMed |
| Recent progress and perspectives on the relationship between hyperuricemia and periodontitis. | Front Immunol | 2022 | 36466813 | PubTator, text mining | PubMed |
| Bruton's tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review. | Front Oncol | 2022 | 36465385 | PubTator, text mining | PubMed |
| Blocking Caspase-1/Gsdmd and Caspase-3/-8/Gsdme pyroptotic pathways rescues silicosis in mice. | PLoS Genet | 2022 | 36459518 | PubTator, text mining | PubMed |
| Activation of IL1 signaling molecules by Kaposi's sarcoma-associated herpesvirus. | Front Cell Infect Microbiol | 2022 | 36457850 | PubTator, text mining | PubMed |
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation. | Haematologica | 2022 | 36453521 | PubTator, text mining | PubMed |
| TMEM173 rs7447927 genetic polymorphism and susceptibility to severe enterovirus 71 infection in Chinese children. | Immun Inflamm Dis | 2022 | 36444630 | PubTator, text mining | PubMed |
| Comprehensive evaluation of breast cancer immunotherapy and tumor microenvironment characterization based on interleukin genes-related risk model. | Sci Rep | 2022 | 36443508 | PubTator, text mining | PubMed |
| The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement. | Front Neurol | 2022 | 36438941 | PubTator, text mining | PubMed |
| Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes. | Cancers (Basel) | 2022 | 36428749 | PubTator, text mining | PubMed |
| Effects of Klebsiella pneumoniae Bacteriophages on IRAK3 Knockdown/Knockout THP-1 Monocyte Cell Lines. | Viruses | 2022 | 36423191 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=31